Gonorrhea has long been a sexually transmitted disease that is treated with a strong dose of antibiotics. However, it may soon become untreatable as it develops resistance to the two antibiotics left that can treat it: azithromycin and ceftriaxon.
CBS News reports that antibiotic resistant strains of this STD have more than quadrupled in the United States.
Dr. Jonathan Mermin, director of the Center for Disease Control’s National Center for HIV/AIDS, Viral Hepatitis, STD, and Tuberculosis Prevention, stated:
“The confluence of emerging drug resistance and very limited alternative options for treatment creates a perfect storm for future gonorrhea treatment failure in the U.S.”
However, the rates of antibiotic resistant strains are still low, despite the fourfold increase in gonorrhea that is resistant to azithromycin. The rate recently rose from 0.6 percent to 2.5 percent. For the other drug used to treat the disease, ceftriaxon, antibiotic resistance has doubled from 0.4 percent to 0.8 percent. Again,